Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin

British Journal of Dermatology

Volumn 171, Issue 3, 2014, Pages 505-511

  Kay, A B ^a   Ying, S ^b   Ardelean, E ^c   Mlynek, A ^c   Kita, H ^d   Clark, P ^a   Maurer, M ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD31 ANTIGEN; ULEX EUROPAEUS AGGLUTININ; VASCULOTROPIN;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BASOPHIL; BLOOD VESSEL PERMEABILITY; CD3+ T LYMPHOCYTE; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DERMAL MICROVASCULAR ENDOTHELIAL CELL; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MACROPHAGE; MALE; MAST CELL; MICROVASCULATURE; MIDDLE AGED; NEUTROPHIL COUNT; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN BLOOD VESSEL; SKIN BLOOD VESSEL DISORDER; SKIN DEFECT; VASCULAR ENDOTHELIUM; BLOOD VESSEL; CASE CONTROL STUDY; CHRONIC DISEASE; LEUKOCYTE; LEUKOCYTOSIS; METABOLISM; PATHOLOGY; SKIN; URTICARIA; VASCULARIZATION;

ADULT; AGED; BIOMARKERS; BLOOD VESSELS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; LEUKOCYTES; LEUKOCYTOSIS; MALE; MAST CELLS; MIDDLE AGED; SKIN; URTICARIA;

EID: 84925260705     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12991     Document Type: Article

References (21)

1. Greaves M,. Chronic urticaria. J Allergy Clin Immunol 2000; 105: 664-72.
2. Hide M, Francis DM, Grattan CE, et al,. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-604.
3. Eckman JA, Hamilton RG, Gober LM, et al,. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol 2008; 128: 1956-63.
4. Ying S, Kikuchi Y, Meng Q, et al,. Th1/Th2 cytokines and inflammatory cells in skin biopsies from chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109: 694-700.
5. Sabroe RA, Poon E, Orchard GE, et al,. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Allergy Clin Immunol 1999; 103: 484-93.
6. Wedmore CV, Williams TJ,. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981; 289: 646-50.
7. Piliponsky AM, Gleich GJ, Bar I, Levi-Schaffer F,. Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Mol Immunol 2002; 38: 1369.
8. Nakamura Y, Kambe N, Saito M, et al,. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 2009; 206: 1037-46.
9. Haas N, Toppe E, Henz BM,. Microscopic morphology of different types of urticaria. Arch Dermatol 1998; 134: 41-6.
10. Natbony SF, Phillips ME, Elias JM, et al,. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 1983; 71: 177-83.
11. Smith CH, Kepley C, Schwartz LB, Lee TH,. Mast cell number and phenotype in chronic idiopathic urticaria. J Allergy Clin Immunol 1995; 96: 360-4.
12. Zuberbier T, Asero R, Bindslev-Jensen C, et al,. Dermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-43.
13. Ying S, Robinson DS, Meng Q, et al,. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma and their association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997; 27: 3507-16.
14. Hashimoto M, Tanaka H, Abe H,. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 2005; 127: 965-72.
15. Corrigan CJ, Wang W, Meng Q, et al,. T-helper cell type 2 (Th2) memory T cell-potentiating cytokine 25 has the potential to promote angiogenesis in asthma. Proc Natl Acad Sci USA 2011; 108: 1579-84.
16. Williams MJ, Lowrie MB, Bennett JP, et al,. Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse. Brain Res 2005; 1058: 62-72.
17. Leiferman KM, Ackerman SJ, Sampson HA, et al,. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 1985; 313: 282-5.
18. Tedeschi A, Asero R, Lorini M, et al,. Serum eotaxin levels in patients with chronic spontaneous urticaria. Eur Ann Allergy Clin Immunol 2012; 44: 188-92.
19. Hippenstiel S, Krüll M, Ikemann A, et al,. VEGF induces hyperpermeability by a direct action on endothelial cells. Am J Physiol 1998; 274: L678-84.
20. Grattan CE, Walpole D, Francis DM, et al,. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997; 27: 1417-24.
21. Zuberbier T, Schadendorf D, Haas N, et al,. Enhanced P-selectin expression in chronic and dermographic urticaria. Int Arch Allergy Immunol 1997; 114: 86-9.